Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Non-Current Debt (2016 - 2020)

Updated

Vistagen Therapeutics (VTGN) posted Non-Current Debt of $87,300 for fiscal Q2 2021 (quarter ended Sep 30, 2020), down 30.0% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Non-Current Debt (2016 - 2020) Analysis & Trends

At the end of FY2016 (ended Mar 31, 2016), Vistagen Therapeutics' Non-Current Debt came in at $27,200.

  • The fiscal Q2 2021 figure stands as the lowest quarterly Non-Current Debt since fiscal Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 87,300.00
Jun 30, 2020 124,700.00
Mar 31, 2016 27,200.00
API Access

Vistagen Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=VTGN&period=max&api_key=YOUR_API_KEY